1.81
price down icon5.24%   -0.10
after-market Dopo l'orario di chiusura: 1.82 0.01 +0.55%
loading
Precedente Chiudi:
$1.91
Aprire:
$1.94
Volume 24 ore:
2.04M
Relative Volume:
0.69
Capitalizzazione di mercato:
$481.72M
Reddito:
-
Utile/perdita netta:
$-208.38M
Rapporto P/E:
-1.5083
EPS:
-1.2
Flusso di cassa netto:
$-156.57M
1 W Prestazione:
-3.21%
1M Prestazione:
+21.48%
6M Prestazione:
-26.72%
1 anno Prestazione:
-24.90%
Intervallo 1D:
Value
$1.80
$1.97
Intervallo di 1 settimana:
Value
$1.77
$2.07
Portata 52W:
Value
$1.105
$2.70

Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile

Name
Nome
Autolus Therapeutics Plc Adr
Name
Telefono
44 20 3829 6230
Name
Indirizzo
THE MEDIAWORKS, LONDON
Name
Dipendente
647
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-12
Name
Ultimi documenti SEC
Name
AUTL's Discussions on Twitter

Confronta AUTL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
AUTL
Autolus Therapeutics Plc Adr
1.81 508.33M 0 -208.38M -156.57M -1.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
463.86 119.17B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
796.55 84.19B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
398.29 52.77B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
788.49 48.98B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
175.97 36.31B 447.02M -1.18B -906.14M -6.1812

Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-18 Aggiornamento Goldman Neutral → Buy
2024-11-15 Aggiornamento Redburn Atlantic Neutral → Buy
2023-11-09 Iniziato Deutsche Bank Buy
2023-03-27 Ripresa Wells Fargo Overweight
2023-03-17 Iniziato Bryan Garnier Buy
2021-06-14 Aggiornamento Jefferies Hold → Buy
2021-01-29 Downgrade JP Morgan Overweight → Neutral
2020-12-28 Ripresa H.C. Wainwright Buy
2020-07-31 Iniziato JP Morgan Overweight
2020-07-22 Iniziato SunTrust Buy
2020-04-22 Iniziato Mizuho Buy
2019-09-23 Iniziato Needham Buy
2019-05-17 Reiterato H.C. Wainwright Buy
2018-10-24 Iniziato H.C. Wainwright Buy
Mostra tutto

Autolus Therapeutics Plc Adr Borsa (AUTL) Ultime notizie

pulisher
Jan 07, 2026

Free cash flow per share of Autolus Therapeutics Plc Sponsored ADR – FWB:6A3A - TradingView — Track All Markets

Jan 07, 2026
pulisher
Dec 30, 2025

Autolus Therapeutics (NASDAQ:AUTL) Price Target Raised to $11.00 at Needham & Company LLC - Defense World

Dec 30, 2025
pulisher
Dec 30, 2025

Autolus Therapeutics (NASDAQ:AUTL) Trading Up 13.5% Following Analyst Upgrade - Defense World

Dec 30, 2025
pulisher
Dec 29, 2025

Autolus Therapeutics stock jumps after Needham raises price target By Investing.com - Investing.com South Africa

Dec 29, 2025
pulisher
Dec 27, 2025

Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now? - Finviz

Dec 27, 2025
pulisher
Dec 22, 2025

Perpetual Ltd Has $784,000 Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World

Dec 22, 2025
pulisher
Dec 19, 2025

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Dec 19, 2025
pulisher
Dec 15, 2025

The i-80 Gold Corp (IAUX) had a good session last reading, didn’t it? - uspostnews.com

Dec 15, 2025
pulisher
Dec 15, 2025

Autolus Therapeutics’ (AUTL) “Buy” Rating Reiterated at Needham & Company LLC - Defense World

Dec 15, 2025
pulisher
Dec 09, 2025

Views of Wall Street’s Leading Experts on Autolus Therapeutics plc ADR - setenews.com

Dec 09, 2025
pulisher
Dec 09, 2025

Wall Street analysts’ outlook for AlphaVest Acquisition Corp (ATMV) - setenews.com

Dec 09, 2025
pulisher
Dec 02, 2025

Check Out Autolus Therapeutics plc ADR (AUTL)’s Trade Data Rather Than the Analysts’ Views - Setenews

Dec 02, 2025
pulisher
Dec 02, 2025

Cetera Investment Advisers Has $1.41 Million Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World

Dec 02, 2025
pulisher
Dec 01, 2025

Ryan Richardson joins Autolus Therapeutics board of directors - Investing.com

Dec 01, 2025
pulisher
Nov 25, 2025

An analyst sees good growth prospects for Autolus Therapeutics plc ADR (AUTL) - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

Taking on analysts’ expectations and winning: EON Resources Inc (EONR) - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

Ready to Jump After Recent Trade: BitMine Immersion Technologies Inc (BMNR) - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

Iterum Therapeutics Plc (ITRM) Performance and Fundamentals Dashboard tells a completely different story - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

Taking on analysts’ expectations and winning: enVVeno Medical Corporation (NVNO) - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

Check out these key findings about Streamex Corp (STEX) - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

This trade activity should not be overlooked: ETHZilla Corp (ETHZ) - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

A better buy-in window may exist right now for Centessa Pharmaceuticals plc ADR (CNTA) - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

How does Advanced Biomed Inc (ADVB) change from a tortoise to a hare? - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

A look into Mobile health Network Solutions (MNDR)’s deeper side - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

Traws Pharma Inc (TRAW) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

Taking on analysts’ expectations and winning: Gelteq Ltd (GELS) - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

Wall Street analysts’ outlook for Amaze Holdings Inc (AMZE) - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

Is Autolus Therapeutics PLC (AUTL) One of the Fastest-Growing Penny Stocks to Buy Now? - Finviz

Nov 25, 2025
pulisher
Nov 25, 2025

NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (≥26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹ - GlobeNewswire Inc.

Nov 25, 2025
pulisher
Nov 24, 2025

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Nov 24, 2025
pulisher
Nov 24, 2025

ADC Therapeutics SA (NYSE:ADCT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Nov 24, 2025
pulisher
Nov 21, 2025

A new trading data show Ashford Hospitality Trust Inc (AHT) is showing positive returns. - Setenews

Nov 21, 2025
pulisher
Nov 21, 2025

Taking on analysts’ expectations and winning: Houston American Energy Corp (HUSA) - Setenews

Nov 21, 2025
pulisher
Nov 21, 2025

Does Klotho Neurosciences Inc (KLTO) offer a good opportunity for investors? - Setenews

Nov 21, 2025
pulisher
Nov 21, 2025

The time has not yet come to remove your chips from the table: Psyence Biomedical Ltd (PBM) - Setenews

Nov 21, 2025
pulisher
Nov 20, 2025

Newsmax Inc (NMAX) can make a big difference with a little luck - Setenews

Nov 20, 2025
pulisher
Nov 20, 2025

Check Out Dolly Varden Silver Corp (DVS)’s Trade Data Rather Than the Analysts’ Views - Setenews

Nov 20, 2025
pulisher
Nov 20, 2025

Views of Wall Street’s Leading Experts on Viomi Technology Co Ltd ADR - Setenews

Nov 20, 2025
pulisher
Nov 19, 2025

Are Smart Investors Making the Right Decision? Empery Digital Inc (EMPD) - Setenews

Nov 19, 2025
pulisher
Nov 19, 2025

Wall Street analysts’ outlook for Picard Medical Inc (PMI) - Setenews

Nov 19, 2025
pulisher
Nov 18, 2025

Autolus Therapeutics plc ADR (AUTL) is looking forward to a strong quarter - Setenews

Nov 18, 2025
pulisher
Nov 18, 2025

Views of Wall Street’s Leading Experts on Twin Vee PowerCats Co - Setenews

Nov 18, 2025
pulisher
Nov 18, 2025

This trade activity should not be overlooked: Amaze Holdings Inc (AMZE) - Setenews

Nov 18, 2025
pulisher
Nov 18, 2025

Wall Street analysts’ outlook for Cypherpunk Technologies Inc (CYPH) - Setenews

Nov 18, 2025
pulisher
Nov 17, 2025

William Blair Issues Pessimistic Forecast for AUTL Earnings - Defense World

Nov 17, 2025
pulisher
Nov 17, 2025

There is no doubt that Cycurion Inc (CYCU) ticks all the boxes. - Setenews

Nov 17, 2025
pulisher
Nov 14, 2025

Check Out SIGA Technologies Inc (SIGA)’s Trade Data Rather Than the Analysts’ Views - Setenews

Nov 14, 2025
pulisher
Nov 14, 2025

How Autolus Therapeutics plc (Common Stock) (6A3A) stock moves on employment data2025 Price Targets & Weekly High Momentum Picks - newser.com

Nov 14, 2025
pulisher
Nov 12, 2025

Top investors say Autolus Therapeutics plc ADR (AUTL) ticks everything they need - Setenews

Nov 12, 2025
pulisher
Nov 11, 2025

Pony AI Inc. ADR (PONY) can make a big difference with a little luck - Setenews

Nov 11, 2025
pulisher
Nov 10, 2025

Are These 4 Biotech Stocks Set to Beat Q3 Earnings Estimates? - TradingView

Nov 10, 2025

Autolus Therapeutics Plc Adr Azioni (AUTL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Capitalizzazione:     |  Volume (24 ore):